Lilly and insitro team up to develop AI-powered siRNA metabolic drugs
Eli Lilly has teamed up with insitro to develop treatments for metabolic diseases, combining insitro’s artificial intelligence (AI) machine learning (ML) platform with Lilly’s drug delivery technology. The deal, which involves three strategic agreements, …